NITROGEN IN FECAL BACTERIAL, FIBER, AND SOLUBLE FRACTIONS OF PATIENTS WITH CIRRHOSIS - EFFECTS OF LACTULOSE AND LACTULOSE PLUS NEOMYCIN

被引：0
|
作者：
WEBER, FL
BANWELL, JG
FRESARD, KM
CUMMINGS, JH
机构：
[1] MRC,DUNN CLIN NUTR CTR,CAMBRIDGE,ENGLAND
[2] VET ADM MED CTR,CLEVELAND,OH 44106
[3] CASE WESTERN RESERVE UNIV,SCH MED,DEPT MED,DIV GASTROENTEROL & NUTR,CLEVELAND,OH 44106
来源：
JOURNAL OF LABORATORY AND CLINICAL MEDICINE | 1987年 / 110卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：259 / 263
页数：5
相关论文
共 16 条
  • [1] EFFECT OF LACTULOSE AND LACTULOSE PLUS NEOMYCIN ON THE COMPARTMENTALIZATION OF STOOL NITROGEN
    WEBER, FL
    BANWELL, JG
    FRESARD, KF
    CUMMINGS, JH
    GASTROENTEROLOGY, 1982, 82 (05) : 1208 - 1208
  • [2] Effects of lactulose on intestinal bacterial flora and fecal organic acids in patients with liver cirrhosis
    Murawaki, Y
    Kobayashi, M
    Koda, M
    Kawasakia, H
    HEPATOLOGY RESEARCH, 2000, 17 (01) : 56 - 64
  • [3] COMPARISON OF LACTULOSE AND NEOMYCIN EFFECTS BY ASSAY OF FECAL UREASE ACTIVITY
    SWEENEY, D
    COHEN, J
    MATTHEWS, J
    GOLDEN, B
    GRACE, ND
    GASTROENTEROLOGY, 1980, 79 (05) : 1057 - 1057
  • [4] EFFECT OF LACTULOSE AND NEOMYCIN ALONE OR IN COMBINATION ON BACTERIAL H-2-PRODUCTION IN PATIENTS WITH CIRRHOSIS
    VOGELSANG, H
    FERENCI, P
    STANEK, G
    WEWALKA, G
    MERYN, S
    GANGL, A
    HEPATOLOGY, 1986, 6 (05) : 1157 - 1157
  • [5] Faecal bacterial microbiota in patients with cirrhosis and the effect of lactulose administration
    Sarangi, Aditya Narayan
    Goel, Amit
    Singh, Ankur
    Sasi, Avani
    Aggarwal, Rakesh
    BMC GASTROENTEROLOGY, 2017, 17
  • [6] Faecal bacterial microbiota in patients with cirrhosis and the effect of lactulose administration
    Aditya Narayan Sarangi
    Amit Goel
    Ankur Singh
    Avani Sasi
    Rakesh Aggarwal
    BMC Gastroenterology, 17
  • [7] THE EFFECT OF LACTULOSE AND LACTITOL ADMINISTRATION ON FECAL FAT EXCRETION IN PATIENTS WITH LIVER-CIRRHOSIS
    MERLI, M
    CASCHERA, M
    PIAT, C
    PINTO, G
    DIOFEBI, M
    RIGGIO, O
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 1992, 15 (02) : 125 - 127
  • [8] Six-week administration of lactulose in patients with cirrhosis does not alter the gut bacterial flora
    Goel, Amit
    Sarangi, Aditya N.
    Singh, Ankur
    Avani, S.
    Aggarwal, Rakesh
    HEPATOLOGY, 2015, 62 : 930A - 930A
  • [9] The Modest Differential Effects of Rifaximin Alone vs Rifaximin Plus Lactulose on Intestinal Microbial Diversity and Composition in Patients With Cirrhosis
    Frenette, Catherine
    Sundaram, Vinay
    Heimanson, Zeev
    Israel, Robert
    Sanyal, Arun
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S517 - S518
  • [10] Impact of rifaximin monotherapy or rifamixin plus lactulose on markers of inflammation in patients with cirrhosis and a history of hepatic encephalopathy
    Sanyal, Arun
    Heimanson, Zeev
    Flamm, Steven
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E677 - E678
12